20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

Understanding Dasatinib: A Powerful BCR-ABL Inhibitor in Cancer Research

NINGBO INNO PHARMCHEM CO.,LTD. is a leading provider of research chemicals, including the highly effective Dasatinib 302962-49-8. This potent small molecule inhibitor has become indispensable in the study and treatment of cancers driven by aberrant kinase activity, particularly those involving the BCR-ABL fusion protein.

Chronic Myeloid Leukemia (CML) is a prime example where Dasatinib has revolutionized treatment. The development of resistance to earlier therapies like imatinib underscored the need for agents with different mechanisms or enhanced potency. Dasatinib, as a potent BCR-ABL inhibitor, effectively targets this abnormal protein, disrupting the signaling pathways that lead to uncontrolled cell proliferation. Its ability to overcome imatinib resistance is a testament to its advanced therapeutic profile, making it a critical tool for clinicians and researchers.

Beyond CML, the research into Dasatinib's applications is extensive. Its role as a SRC family kinase inhibitor means it has potential in treating a broader spectrum of cancers where these kinases are overactive. This versatility makes it a valuable asset in preclinical and clinical research, allowing scientists to explore new therapeutic avenues. Accessing high-quality Dasatinib from a reputable Dasatinib supplier China like NINGBO INNO PHARMCHEM CO.,LTD. is crucial for ensuring the reliability of research outcomes.

The availability of pharmaceutical chemical raw material such as Dasatinib is foundational to scientific progress. NINGBO INNO PHARMCHEM CO.,LTD. is committed to providing researchers with the compounds they need to advance their work. By offering this compound for researchers to buy Dasatinib online, we facilitate quicker access to critical materials, thereby accelerating the pace of discovery in oncology and related fields. Our dedication to purity and quality ensures that every batch meets the rigorous demands of pharmaceutical research.

The continuous exploration of kinase inhibitors is vital for developing more effective and less toxic cancer treatments. Dasatinib represents a significant step forward, and its availability through trusted suppliers like NINGBO INNO PHARMCHEM CO.,LTD. empowers the scientific community to push the boundaries of medical innovation.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: Dasatinib: A Key Pharmaceutical Chemical for Targeted Cancer Therapy

Next: The Therapeutic Potential of Dasatinib: A Leading Tyrosine Kinase Inhibitor

All Rights Reserved